首页> 外文OA文献 >Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

【2h】

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

机译：基因组与临床精密药物是否有不同的证据阈值？基于信息的框架价值适用于抗血小板药物治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gregory F. Guzauskas; Anirban Basu; Josh J. Carlson; David L. Veenstra;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy [J] . Guzauskas Gregory F., Basu Anirban, Carlson Josh J., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2019,第9期

机译：基因组与临床精密药物有不同的证据阈值吗？基于信息的框架价值应用于抗血小板药物治疗
2. Are Evidence Standards Different for Genomic‐ vs. Clinical‐Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy [J] . Dhanda DS, Guzauskas GF, Carlson JJ, Clinical Pharmacology and Therapeutics . 2017,第5期

机译：是基因组和基因组的证据标准。基于临床的精密药？个性化华法林治疗的定量分析
3. Ticagrelor Monotherapy versus Standard Dual Antiplatelet Therapy After Drug-Eluting Coronary Stent Implantation: A Systematic Review and Individual Patient Data Meta-Analysis From the Single versus Dual Antiplatelet Therapy (SIDNEY) Collaboration [J] . Valgimigli Marco, Jueni Peter, Mehran Roxana Circulation: An Official Journal of the American Heart Association . 2019,第25期

机译：TiCagreloRoperapy与标准双抗血小板治疗药物洗脱冠状动脉支架植入：从单一与双抗血小板治疗（Sidney）合作的系统评价和个体患者数据荟萃分析
4. AN INTEGRATED FRAMEWORK FOR REPORTING CLINICALLY RELEVANT BIOMARKERS FROM PAIRED TUMOR/NORMAL GENOMIC AND TRANSCRIPTOMIC SEQUENCING DATA IN SUPPORT OF CLINICAL TRIALS IN PERSONALIZED MEDICINE [C] . SARA NASSER, AHMET A. KURDOLGU, TYLER IZATT, Pacific Symposium on Biocomputing . 2015

机译：一种综合框架，用于报告来自配对肿瘤/正常基因组和转录组序列测序数据的临床相关的生物标志物，以支持个性化医学中的临床试验
5. Toward Precision Medicine: From Clinical Genomics to iPSC Disease Modeling [D] . Wu, Yiyang 2017

机译：迈向精密医学：从临床基因组学到iPSC疾病建模
6. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimers disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study [O] . Harald Hampel, Coralie Williams, Adrien Etcheto, 2020

机译：使用人工智能的精密医学框架用于识别和确认对阿尔茨海默氏病治疗反应的基因组生物标志物：布拉卡米碱（ANAVEX2-73）2a期临床研究的分析
7. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study [O] . Harald Hampel, Coralie Williams, Adrien Etcheto, 2020

机译：一种使用人工智能的精密药框架，用于鉴定和确认对阿尔茨海默病治疗的应对基因组生物标志物：分析Blarcamesine（Anavex2-73）2A期临床研究

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅